Skip to content

Obsidian Therapeutics

US · OBX #3403 by market cap
12.00 -0.15 -1.23%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

After-hours 12.00 0.00%
35.009.6012.002026-07-272026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on OBX?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -40.6% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 1.9% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Performance

1W -4.46%
1M -9.43%
3M -40.56%

Key statistics

Price & volume

Prev close
12.15
Open
12.01
Day range
11.76 - 12.30
Avg price
11.95
Volume
336.50K
Turnover
4.02M
Amplitude
4.44%
52-week range
9.60 - 49.97

Valuation

P/E
18.46
P/E (TTM)
18.46
P/B
2.31
EPS
0.65
Net profit
40.15M
Net assets
320.61M

Share structure

Market cap
741.29M
Float cap
635.45M
Shares out
61.77M
Float shares
52.95M

Dividend & listing

Dividend (TTM)
0.00
Listing date
--
52-week range 6% of range
9.60 49.97

76.0% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-2.81M net over the window

Short interest

Shares short
1.18M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Obsidian Therapeutics (OBX)?

Obsidian Therapeutics last traded at 12.00. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Obsidian Therapeutics's market cap?

About 741.29M.

What is the P/E ratio of Obsidian Therapeutics?

The trailing twelve-month P/E is 18.46, above its own 5-year average of 16.42 — in the middle of its historical range (33.78% percentile). See the Valuation tab for the full history.

Does Obsidian Therapeutics pay a dividend?

Obsidian Therapeutics does not currently pay a regular dividend.

Is Obsidian Therapeutics a buy according to analysts?

The consensus of 2 analysts is a Buy rating, with an average 12-month price target of 43.00, which implies 258.3% upside from the current price. This is not investment advice.

What is Obsidian Therapeutics's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Obsidian Therapeutics a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Obsidian Therapeutics discussion 0 comments

Add a comment